Literature DB >> 24910411

The impact of Nucleofection® on the activation state of primary human CD4 T cells.

Mingce Zhang1, Zhengyu Ma2, Nithianandan Selliah3, Greta Weiss4, Anna Genin5, Terri H Finkel6, Randy Q Cron7.   

Abstract

Gene transfer into primary human CD4 T lymphocytes is a critical tool in studying the mechanism of T cell-dependent immune responses and human immunodeficiency virus-1 (HIV-1) infection. Nucleofection® is an electroporation technique that allows efficient gene transfer into primary human CD4 T cells that are notoriously resistant to traditional electroporation. Despite its popularity in immunological research, careful characterization of its impact on the physiology of CD4 T cells has not been documented. Herein, using freshly-isolated primary human CD4 T cells, we examine the effects of Nucleofection® on CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity. We find that immediately after Nucleofection®, CD4 T cells undergo dramatic morphological changes characterized by wrinkled and dilated plasma membranes before recovering 1h later. The intracellular calcium level also increases after Nucleofection®, peaking after 1h before recovering 8h post transfection. Moreover, Nucleofection® leads to increased expression of T cell activation markers, CD154 and CD69, for more than 24h, and enhances the activation effects of phytohemagglutinin (PHA) stimulation. In addition, transcriptional activity is increased in the first 24h after Nucleofection®, even in the absence of exogenous stimuli. Therefore, Nucleofection® significantly alters the activation state of primary human CD4 T cells. The effect of transferred gene products on CD4 T cell function by Nucleofection® should be assessed after sufficient resting time post transfection or analyzed in light of the activation caveats mentioned above.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium; Gene transfer; HIV-1; Nucleofection®; Plasmid; T cell activation

Mesh:

Substances:

Year:  2014        PMID: 24910411      PMCID: PMC4120863          DOI: 10.1016/j.jim.2014.05.014

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  37 in total

1.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Small interfering RNA-mediated knockdown of notch ligands in primary CD4+ T cells and dendritic cells enhances cytokine production.

Authors:  Yvette Stallwood; Emmanuel Briend; Katrina M Ray; George A Ward; Beverley J Smith; Emma Nye; Brian R Champion; Grahame J McKenzie
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  Phosphatidylinositol 3-kinase functions as a Ras effector in the signaling cascade that regulates dephosphorylation of the actin-remodeling protein cofilin after costimulation of untransformed human T lymphocytes.

Authors:  Guido H Wabnitz; Gabriele Nebl; Martin Klemke; Andreas J Schröder; Yvonne Samstag
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

4.  Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation.

Authors:  Johanna Tahvanainen; Maritta Pykäläinen; Teemu Kallonen; Hanna Lähteenmäki; Omid Rasool; Riitta Lahesmaa
Journal:  J Immunol Methods       Date:  2006-02-08       Impact factor: 2.303

5.  Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells.

Authors:  Marie-Pierre Rols
Journal:  Biochim Biophys Acta       Date:  2006-01-30

6.  Stable nonviral gene transfer into primary human T cells.

Authors:  T Magg; S Hartrampf; M H Albert
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

7.  FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression.

Authors:  Troy R Torgerson; Anna Genin; Chunxia Chen; Mingce Zhang; Bin Zhou; Stephanie Añover-Sombke; M Barton Frank; Igor Dozmorov; Elizabeth Ocheltree; Petri Kulmala; Michael Centola; Hans D Ochs; Andrew D Wells; Randy Q Cron
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

Review 8.  Computer simulations of transport through membranes: passive diffusion, pores, channels and transporters.

Authors:  D Peter Tieleman
Journal:  Clin Exp Pharmacol Physiol       Date:  2006-10       Impact factor: 2.557

9.  FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.

Authors:  Nithianandan Selliah; Mingce Zhang; Sara White; Philip Zoltick; Bassel E Sawaya; Terri H Finkel; Randy Q Cron
Journal:  Virology       Date:  2008-10-01       Impact factor: 3.616

10.  Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways.

Authors:  Christian Grant; Unsong Oh; Kazunori Fugo; Norihiro Takenouchi; Caitlin Griffith; Karen Yao; Timothy E Newhook; Lee Ratner; Steven Jacobson
Journal:  PLoS Pathog       Date:  2006-04-28       Impact factor: 6.823

View more
  13 in total

1.  T cells expressing chimeric antigen receptor promote immune tolerance.

Authors:  Antonio Pierini; Bettina P Iliopoulou; Heshan Peiris; Magdiel Pérez-Cruz; Jeanette Baker; Katie Hsu; Xueying Gu; Ping-Ping Zheng; Tom Erkers; Sai-Wen Tang; William Strober; Maite Alvarez; Aaron Ring; Andrea Velardi; Robert S Negrin; Seung K Kim; Everett H Meyer
Journal:  JCI Insight       Date:  2017-10-19

2.  Photothermal nanofibres enable safe engineering of therapeutic cells.

Authors:  Ranhua Xiong; Dawei Hua; Jelter Van Hoeck; Dominika Berdecka; Laurens Léger; Stijn De Munter; Juan C Fraire; Laurens Raes; Aranit Harizaj; Félix Sauvage; Glenn Goetgeluk; Melissa Pille; Jeffrey Aalders; Joke Belza; Thibaut Van Acker; Eduardo Bolea-Fernandez; Ting Si; Frank Vanhaecke; Winnok H De Vos; Bart Vandekerckhove; Jolanda van Hengel; Koen Raemdonck; Chaobo Huang; Stefaan C De Smedt; Kevin Braeckmans
Journal:  Nat Nanotechnol       Date:  2021-10-21       Impact factor: 39.213

3.  Numerical optimization of microfluidic vortex shedding for genome editing T cells with Cas9.

Authors:  Justin A Jarrell; Brandon J Sytsma; Leah H Wilson; Fong L Pan; Katherine H W J Lau; Giles T S Kirby; Adrian A Lievano; Ryan S Pawell
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents.

Authors:  Kamel Chettab; Stéphanie Roux; Doriane Mathé; Emeline Cros-Perrial; Maxime Lafond; Cyril Lafon; Charles Dumontet; Jean-Louis Mestas
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Optimization of methods for the genetic modification of human T cells.

Authors:  Mahmood Y Bilal; Aldo Vacaflores; Jon Cd Houtman
Journal:  Immunol Cell Biol       Date:  2015-06-01       Impact factor: 5.126

Review 6.  T cells and reactive oxygen species.

Authors:  Aleksey V Belikov; Burkhart Schraven; Luca Simeoni
Journal:  J Biomed Sci       Date:  2015-10-15       Impact factor: 8.410

Review 7.  Microfluidic and Nanofluidic Intracellular Delivery.

Authors:  Jeongsoo Hur; Aram J Chung
Journal:  Adv Sci (Weinh)       Date:  2021-06-06       Impact factor: 16.806

8.  Resolving mechanisms of immune-mediated disease in primary CD4 T cells.

Authors:  Christophe Bourges; Abigail F Groff; Oliver S Burren; Chiara Gerhardinger; Kaia Mattioli; Anna Hutchinson; Theodore Hu; Tanmay Anand; Madeline W Epping; Chris Wallace; Kenneth Gc Smith; John L Rinn; James C Lee
Journal:  EMBO Mol Med       Date:  2020-04-01       Impact factor: 12.137

Review 9.  The cellular response to plasma membrane disruption for nanomaterial delivery.

Authors:  Kevin Braeckmans; Winnok H De Vos; Gaëlle Houthaeve; Stefaan C De Smedt
Journal:  Nano Converg       Date:  2022-02-01

10.  Phosphoproteomics Reveals Regulatory T Cell-Mediated DEF6 Dephosphorylation That Affects Cytokine Expression in Human Conventional T Cells.

Authors:  Rubin N Joshi; Nadine A Binai; Francesco Marabita; Zhenhua Sui; Amnon Altman; Albert J R Heck; Jesper Tegnér; Angelika Schmidt
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.